4/A//SEC Filing
Ianchulev Tsontcho 4/A
Accession 0001104659-25-041549
CIK 0001682639other
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 7:52 PM ET
Size
7.5 KB
Accession
0001104659-25-041549
Insider Transaction Report
Form 4/AAmended
EYENOVIA, INC.EYEN
Ianchulev Tsontcho
Director
Transactions
- Award
Common Stock, par value $.0001
2025-04-21+5,000→ 10,122 total
Holdings
- 75(indirect: By Trust)
Common Stock, par value $.0001
- 7,583(indirect: By Private Medical Equity, Inc.)
Common Stock, par value $.0001
Footnotes (3)
- [F1]Represents restricted stock units that will fully vest upon the closing of the Issuer's proposed business combination with Betaliq, Inc. Vesting is subject to the Reporting Person's continued service to the Issuer.
- [F2]On January 31, 2025, the Issuer effected a reverse stock split of its common stock at a ratio of 1-for-80 (the "Reverse Split"). The Reporting Person's ownership of the Issuer's securities has been adjusted to reflect the impact of the Reverse Split.
- [F3]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
EYENOVIA, INC.
CIK 0001682639
Entity typeother
Related Parties
1- filerCIK 0001728916
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 7:52 PM ET
- Size
- 7.5 KB